Super League Enterprise, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Super League Enterprise, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $2.06M | Mar 19, 2021 |
| FY2020 | Dec 31, 2019 | $1.08M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $1.05M | Mar 23, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.59M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $6.10M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $9.78M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $8.52M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $5.13M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $1.21M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $571.0K | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $362.0K | Mar 23, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($20.72M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($16.64M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($30.33M) | Mar 31, 2025 |
| FY2023 | Sep 30, 2023 | ($9.43M) | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | ($85.45M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($20.75M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($18.73M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($30.68M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | ($20.63M) | Mar 23, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($13.05M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($16.75M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($32.84M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($84.96M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($25.08M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($18.74M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($20.77M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | ($16.16M) | Mar 23, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.91M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.45M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $9.50M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $15.88M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $11.10M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $6.82M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $4.92M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $4.18M | Mar 23, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($10.67M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($11.46M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($15.49M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($19.83M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($22.71M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($14.88M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($13.65M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | ($10.68M) | Mar 23, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $23.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $8.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $149.0K | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $22.0K | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $9.0K | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $73.0K | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $255.0K | Mar 23, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.87M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.71M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $25.33M | Mar 31, 2025 |
| FY2023 | Sep 30, 2023 | $27.24M | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $30.21M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $96.81M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $13.98M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $14.45M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | $4.99M | Mar 23, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.34M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.54M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $15.34M | Mar 31, 2025 |
| FY2023 | Sep 30, 2023 | $10.63M | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $11.01M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $6.11M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $3.04M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.00M | Mar 19, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.53M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $170.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $9.99M | Mar 31, 2025 |
| FY2023 | Sep 30, 2023 | $16.62M | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | $19.20M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $90.70M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $10.94M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $13.44M | Mar 19, 2021 |
| FY2020 | Dec 31, 2018 | ($6.79M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $3.70M | Mar 23, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.86M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.86M | Mar 31, 2025 |
| FY2024 | Dec 31, 2022 | $0 | Mar 31, 2025 |
| FY2022 | Dec 30, 2022 | $8.30M | Mar 31, 2023 |
| FY2023 | Sep 30, 2022 | $50,263.00B | Apr 15, 2024 |
| FY2022 | Sep 29, 2022 | $50.30M | Mar 31, 2023 |
| FY2023 | Jan 1, 2022 | $50.26M | Apr 15, 2024 |
| FY2023 | Dec 31, 2021 | $50.26M | Apr 15, 2024 |
| FY2022 | Dec 31, 2020 | $2.57M | Mar 31, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($289.96M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($270.04M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($249.01M) | Mar 31, 2025 |
| FY2023 | Sep 30, 2023 | ($234.25M) | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | ($210.74M) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | ($125.29M) | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | ($104.54M) | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | ($85.81M) | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | ($55.13M) | Mar 23, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.39M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $1.31M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $7.61M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $2.48M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | $14.53M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | $7.94M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $8.44M | Mar 19, 2021 |
| FY2020 | Dec 31, 2018 | $2.77M | Mar 19, 2021 |
| FY2019 | Dec 31, 2017 | $1.71M | Mar 23, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (40) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (1,123) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (13) | Mar 31, 2025 |
| FY2023 | Sep 30, 2023 | (3) | Apr 15, 2024 |
| FY2023 | Dec 31, 2022 | (45) | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.13M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 33,801 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 4.77M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 1.88M | Apr 15, 2024 |
| FY2022 | Dec 31, 2021 | 36.81M | Mar 31, 2023 |
| FY2021 | Dec 31, 2020 | 15.48M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 8.57M | Mar 19, 2021 |
| FY2019 | Dec 31, 2018 | 4.61M | Mar 23, 2020 |